Senores Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 59 | 38.53 | 46.69 |
| Operating Expense | 40.29 | 29.69 | 33.81 |
| Net Profit | 8.48 | 2.65 | 6.43 |
| Net Profit Margin | 14.37% | 6.88% | 13.77% |
| Earning Per Share | 1.84 | 1.98 | 1.40 |
| EBIDTA | 20.98 | 8.54 | 12.68 |
| Effective Tax Rate | 34.63% | 6.33% | 7.92% |
Particulars
Mar 2026
Revenue59
Operating Expense40.29
Net Profit8.48
Net Profit Margin14.37
Earning Per Share1.84
EBIDTA20.98
Effective Tax Rate34.63
